| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 100.706.873 $ | +29.899.143 $ | +36,8 % | 3 | 82.793.614 $ | +1.834.536 $ | +24,8 % | 5 | 80.959.078 $ | +15.238.047 $ | +37,6 % | 5 | ||||
| Surrozen, Inc./DE | SRZN | → 0 | Neutral | 55.840.754 $ | +14.000.244 $ | +33,5 % | 1 | 41.840.510 $ | +22.508.436 $ | +116,4 % | 1 | 19.332.074 $ | +5.924.103 $ | +44,2 % | 1 |
| Oric Pharmaceuticals, Inc. | ORIC | → 0 | Neutral | 44.861.645 $ | +15.898.089 $ | +54,9 % | 1 | 28.963.556 $ | -13.525.768 $ | -31,8 % | 1 | 42.489.324 $ | +6.550.437 $ | +18,2 % | 1 |
| Tenaya Therapeutics, Inc. | TNYA | → 0 | Neutral | 6.693.006 $ | -8.159.452 $ | -54,9 % | 1 | 14.852.458 $ | +9.108.881 $ | +158,6 % | 1 | ||||
| RAPT Therapeutics, Inc. | RAPT | → 0 | 5.292.878 $ | +1.009.804 $ | +23,6 % | 1 | 4.283.074 $ | -6.345.830 $ | -59,7 % | 1 | |||||
| Revolution Medicines, Inc. | RVMD | → 0 | Schwach | 4.474 $ | +810 $ | +22,1 % | 1 | 3.664 $ | +1.516 $ | +70,6 % | 1 | 2.148 $ | +456 $ | +27,0 % | 1 |
| 100.706.873 $ | +29.899.143 $ | +36,8 % | 3 | 82.793.614 $ | +1.834.536 $ | +24,8 % | 5 | 80.959.078 $ | +15.238.047 $ | +37,6 % | 5 | ||||